levodopa has been researched along with manganese in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adlmici, G; Callea, L; Di Monda, V; Fazzari, G | 1 |
| Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
| Barbeau, A; Cloutier, T; Inoué, N | 1 |
| Cotzias, GC; Hsieh, RS; Kraner, HW; Miller, ST; Papavasiliou, PS | 1 |
| Barbeau, A; Inoue, N; Tsukada, Y | 1 |
| Garnett, ES; Lang, AE | 1 |
| Aime, S; Botta, M; Camurati, I | 1 |
| Barbeau, A; Cloutier, T; Donaldson, J; Minnich, JL | 1 |
| Barnett, TA; Hageman, JH; Riner, S; Valenzuela, D | 1 |
| Barbeau, A | 1 |
| Cherian, MG; Scheuhammer, AM | 1 |
| Chandra, SV; Shukla, GS | 1 |
| Calne, DB; Chu, NS; Hochberg, F; Huang, CC; Lilienfeld, D; Lu, CS; Olanow, W | 1 |
| Aguilar, MV; de Bustos, F; González-Muñoz, MJ; Jiménez-Jiménez, FJ; Martínez-Para, MC; Martínez-Salio, A; Mateos-Vega, CJ; Meseguer, I; Molina, JA; Ortí-Pareja, M; Zurdo, M | 1 |
| Friedman, MB; Snyder, RD | 1 |
| Delogu, MR; Desole, MS; Enrico, P; Esposito, G; Grella, G; Miele, E; Miele, M; Migheli, R; Mura, MA; Serra, PA | 1 |
| Liu, MC; Ranasinghe, JG; Sakakibara, Y; Suiko, M | 1 |
| Chu, NS | 1 |
| Finkelstein, MM; Jerrett, M | 1 |
| Cai, Z; Hu, M; Hu, Q; Wei, F; Xu, G; Yang, J; Yu, H | 1 |
| Abboud, H; Lakhan, SE | 1 |
| Narayanan, KB; Park, HH | 1 |
22 other study(ies) available for levodopa and manganese
| Article | Year |
|---|---|
[On a muscular dystony case from manganism. Therapeutic clinic considerations (author's transl)].
Topics: Benserazide; Diazepam; Dystonia; Haloperidol; Humans; Hydrazines; Levodopa; Male; Manganese; Middle Aged | 1979 |
The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
Topics: Acetonitriles; Animals; Brain Chemistry; Bromocriptine; Copper; Ergolines; Guinea Pigs; Iron; Levodopa; Male; Manganese; Metals | 1978 |
Role of manganese in dystonia.
Topics: Animals; Brain; Brain Chemistry; Dogs; Dystonia Musculorum Deformans; Functional Laterality; Gait; Haplorhini; Humans; Levodopa; Manganese; Manganese Poisoning; Movement Disorders; Parkinson Disease; Rabbits; Rats; Synapses; Syndrome | 1976 |
Sequential analysis: manganese, catecholamines and L-dopa induced dyskinesia.
Topics: Animals; Brain Chemistry; Cats; Caudate Nucleus; Cerebral Cortex; Corpus Callosum; Dihydroxyphenylalanine; Dopamine; Hypothalamus; Levodopa; Male; Manganese; Methods; Movement Disorders | 1975 |
Behavioral effects in rats following intrastriatal microinjection of manganese.
Topics: Aggression; Animals; Behavior, Animal; Benserazide; Calcium Chloride; Caudate Nucleus; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hydroxydopamines; Levodopa; Male; Manganese; Methyltyrosines; Motor Activity; Pargyline; Rats; Time Factors | 1975 |
Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans.
Topics: Corpus Striatum; Fluorine Radioisotopes; Humans; Levodopa; Manganese; Parkinson Disease, Secondary; Substantia Nigra; Tomography, Emission-Computed | 1990 |
NMR studies of L-dopa melanin-manganese(II) complex in water solution.
Topics: Binding Sites; Levodopa; Magnetic Resonance Spectroscopy; Manganese; Melanins; Solutions; Water | 1989 |
Trace metals and biogenic amines in rat brain.
Topics: Animals; Behavior, Animal; Brain Chemistry; Cerebellum; Cerebral Cortex; Copper; Corpus Striatum; Hippocampus; Levodopa; Manganese; Medulla Oblongata; Mesencephalon; Olfactory Bulb; Rats; Reserpine; Zinc | 1974 |
Production by Bacillis subtilis of brown sporulation-associated pigments.
Topics: Bacillus subtilis; Culture Media; Histidine; Hydrogen-Ion Concentration; Levodopa; Manganese; Metals; Oxygen; Pigments, Biological; Spores, Bacterial; Tyrosine | 1983 |
Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Brain Chemistry; Catecholamines; Disease Models, Animal; Humans; Levodopa; Manganese; Manganese Poisoning; Melanins; Melanocyte-Stimulating Hormones; Parkinson Disease; Substantia Nigra | 1984 |
The distribution and excretion of manganese: the effects of manganese dose, L-dopa, and pretreatment with zinc.
Topics: Animals; Bile; Dose-Response Relationship, Drug; Levodopa; Liver; Male; Manganese; Radioisotopes; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution; Zinc | 1982 |
Striatal dopamine turnover and L-dopa treatment after short-term exposure of rats to manganese.
Topics: Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Manganese; Manganese Poisoning; Rats | 1981 |
Progression after chronic manganese exposure.
Topics: Adult; Chronic Disease; Follow-Up Studies; Humans; Levodopa; Male; Manganese; Middle Aged; Movement Disorders; Nervous System Diseases; Occupational Exposure; Parkinson Disease, Secondary | 1993 |
Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Blood Proteins; Copper; Dopamine Agonists; Female; Humans; Iron; Levodopa; Male; Manganese; Metals, Heavy; Middle Aged; Nutritional Status; Parkinson Disease; Reference Values; Selegiline; Spectrophotometry, Atomic; Trace Elements; Vitamin A; Zinc | 1998 |
Enhancement of cytotoxicity and clastogenicity of l-DOPA and dopamine by manganese and copper.
Topics: Animals; Cell Division; Cell Line; Copper; Cricetinae; Cysteine; Dopamine; Glutathione; Levodopa; Lung; Manganese; Melanins; Micronucleus Tests; Mutagens; Parkinson Disease | 1998 |
Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Chlorides; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis Solutions; Dopamine; Homovanillic Acid; Infusion Pumps; Levodopa; Male; Manganese; Manganese Compounds; Microdialysis; Movement; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Wistar; Time Factors; Uric Acid | 2000 |
Manganese administration induces the increased production of dopamine sulfate and depletion of dopamine in Sprague-Dawley rats.
Topics: Administration, Oral; Animals; Brain; Chromatography, High Pressure Liquid; Dopamine; Heart; Kidney; Levodopa; Liver; Male; Manganese; Manganese Poisoning; Rats; Rats, Sprague-Dawley; Tyrosine | 2000 |
Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
Topics: Age of Onset; Brain; Clinical Trials as Topic; Diagnosis, Differential; Diagnostic Errors; Dopamine Agents; Double-Blind Method; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Manganese; Manganese Poisoning; Occupational Exposure; Parkinson Disease, Secondary; Tremor; Welding | 2004 |
A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities.
Topics: Adult; Aged; Air Pollutants; Antiparkinson Agents; Canada; Case-Control Studies; Cities; Cohort Studies; Humans; Levodopa; Manganese; Middle Aged; Parkinson Disease; Vehicle Emissions | 2007 |
Citrate-capped Mn-modified CdSe/CdS quantum dots as luminescent probes for levodopa detection in aqueous solution.
Topics: Antiparkinson Agents; Cadmium Compounds; Citric Acid; Levodopa; Luminescence; Manganese; Pharmaceutical Preparations; Quantum Dots; Selenium Compounds; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfides | 2012 |
Teaching neuroimages: manganese neurotoxicity of the basal ganglia and thalamus.
Topics: Adult; Basal Ganglia; Chelation Therapy; Cholestasis; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Male; Manganese; Neuroimaging; Neurology; Neurotoxicity Syndromes; Thalamus | 2013 |
Colorimetric detection of manganese(II) ions using gold/dopa nanoparticles.
Topics: Cations, Divalent; Colorimetry; Gold; Levodopa; Manganese; Nanoparticles; Particle Size | 2014 |